201 related articles for article (PubMed ID: 10599907)
1. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
Kamali F; McLaughlin WS; Ball DE; Seymour RA
J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907
[TBL] [Abstract][Full Text] [Related]
2. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
Ball DE; McLaughlin WS; Seymour RA; Kamali F
J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth.
Kamali F; Ball DE; McLaughlin WS; Seymour RA
J Periodontal Res; 1999 Apr; 34(3):145-53. PubMed ID: 10384402
[TBL] [Abstract][Full Text] [Related]
4. Is oral azithromycin effective for the treatment of phenytoin-induced gingival overgrowth in epileptic patients?
Namazi S; Borhani Haghighi A; Karimzadeh I
Med Hypotheses; 2007; 69(5):1159-60. PubMed ID: 17141420
[No Abstract] [Full Text] [Related]
5. Lack of pathogenic mutations in SOS1 gene in phenytoin-induced gingival overgrowth patients.
Margiotti K; Pascolini G; Consoli F; Guida V; Di Bonaventura C; Giallonardo AT; Pizzuti A; De Luca A
Arch Oral Biol; 2017 Aug; 80():160-163. PubMed ID: 28433619
[TBL] [Abstract][Full Text] [Related]
6. Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth.
Sasaki T; Maita E
J Clin Periodontol; 1998 Jan; 25(1):42-7. PubMed ID: 9477019
[TBL] [Abstract][Full Text] [Related]
7. Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.
Lin CJ; Yen MF; Hu OY; Lin MS; Hsiong CH; Hung CC; Liou HH
Pharmacotherapy; 2008 Jan; 28(1):35-41. PubMed ID: 18154472
[TBL] [Abstract][Full Text] [Related]
8. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
[TBL] [Abstract][Full Text] [Related]
9. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect.
Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
J Indian Soc Pedod Prev Dent; 2004 Jun; 22(2):82-91. PubMed ID: 15491092
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin-induced severe gingival overgrowth in a child.
Kumar R; Singh RK; Verma N; Verma UP
BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25053668
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin-induced gingival overgrowth in un-cooperated epilepsy patients.
Marakoglu I; Gursoy UK; Cakmak H; Marakoglu K
Yonsei Med J; 2004 Apr; 45(2):337-40. PubMed ID: 15119009
[TBL] [Abstract][Full Text] [Related]
12. Gingival overgrowth induced by anticonvulsant drugs: A cross-sectional study on epileptic patients.
Gallo C; Bonvento G; Zagotto G; Mucignat-Caretta C
J Periodontal Res; 2021 Apr; 56(2):363-369. PubMed ID: 33368283
[TBL] [Abstract][Full Text] [Related]
13. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
Thomason JM; Seymour RA; Rawlins MD
Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.
Brunet L; Miranda J; Roset P; Berini L; Farré M; Mendieta C
Eur J Clin Invest; 2001 Sep; 31(9):781-8. PubMed ID: 11589720
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin-induced gingival overgrowth.
Arya R; Gulati S
Acta Neurol Scand; 2012 Mar; 125(3):149-55. PubMed ID: 21651505
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced gingival overgrowth after phenytoin and nifedipine therapy. A case report.
Slezák R
J West Soc Periodontol Periodontal Abstr; 1997; 45(4):105-7. PubMed ID: 9571890
[No Abstract] [Full Text] [Related]
17. Role of nuclear factor kappa-B in phenytoin-induced gingival overgrowth.
Arabaci T; Köse O; Kizildağ A; Albayrak M; Ciçek Y; Kara A
Oral Dis; 2014 Apr; 20(3):294-300. PubMed ID: 23651365
[TBL] [Abstract][Full Text] [Related]
18. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
[TBL] [Abstract][Full Text] [Related]
19. Gingival overgrowth in partially edentulous ridges in an elderly female patient with epilepsy: a case report.
Dhingra K; Prakash S
Gerodontology; 2012 Jun; 29(2):e1201-6. PubMed ID: 22612838
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth.
McLaughlin WS; Ball DE; Seymour RA; Kamali F; White K
J Clin Periodontol; 1995 Dec; 22(12):942-5. PubMed ID: 8613563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
